|
|
|
| Home > For Researchers > Overview |
|
| |
|
| |
Research in the 21st century is multi-disciplinary and encompasses many areas and disciplines. This involves a range of professions including clinicians, scientists, physicists, mathematicians and IT specialists. Because of the multi-disciplinary emphasis on NCC research, all NCCS departments are actively encouraged to participate in research work.
As the nation's resource for integrated cancer care, we are deeply engaged in basic, clinical and translational cancer research. Translational research, which
|
|
is research that has direct application to everyday life, potentially can be applied to improve clinical care. Because of the unique integrated organisational structure of the NCCS, research carried out here can find immediate and direct application in clinical practice. This investment in biomedical research reflects the conviction that a strong research ethos is an essential underpinning of high standards of clinical practice. To this end, three research divisions have been established - Division of Cellular and Molecular Research, Division of Medical Sciences, and Division of Clinical Trials & Epidemiological Sciences - staffed by full-time scientists who work in collaboration with cancer specialists of various disciplines.
Research Divisions
The Division of Cellular and Molecular Research is engaged in gene therapy, gene knockouts and transcriptional regulation of genes. The Division of Medical Sciences fosters translational research with the objective of applying advances in basic research (including new diagnostic and therapeutic technologies) to clinical care. The Division of Clinical Trials & Epidemiological Sciences applies the latest advances to the treatment of patients, providing consultancy in biostatistics, clinical trial design and execution. This Division investigates the epidemiology of cancers, and maintain databases that combine epidemiological information with treatment and survival data.
Research Facilities
The Centre's research laboratories occupy approximately 5,000 square metres, one-third of the total floor area of the NCCS. Core research infrastructure includes a genetic microarray system, flow cytometry, confocal microscopy, DNA sequencing, animal holding rooms, biohazard containment and GMP facilities for the preparation of clinical-grade research materials. These facilities are also available to cancer researchers from other hospitals and institutions for collaboration purposes. Industrial partners are also encouraged to undertake collaborative research & development with NCCS.
As the focal point in the nation for cancer prevention and management, NCCS also develops and manages treatment-based registries of major cancers in Singapore. National epidemiological and clinical data are obtained to facilitate objective evaluation of treatment protocols and survival rates. These in-depth treatment-related databases will assess new therapeutic strategies for clinical outcomes and cost effectiveness.
In aspiring to be the premier regional cancer centre, the NCCS is strongly committed to research, education and training. It actively fosters and supports cancer research to further develop and strengthen Singapore's biomedical industry. Research programmes are expected to result in generation of intellectual property, patents and commercial/industrial partnerships with biotechnology, pharmaceutical and instrumentation companies. Future leaders of the medical profession in Singapore will emerge by laying the foundation for a career development pathway through its Clinician-Scientist programme. Its research programmes will also provide Singapore with successive generations of biomedical innovators and technopreneurs.
|
|
 |
| |
| |
|
